Gene expression is mediated by chromatin epigenetic changes, including DNA methylation, histone modifications, promoter-enhancer interactions, and non-coding RNA (microRNA and long non-coding RNA)-mediated regulation (Chen et al., 2017) . Approximately 50 % of all tumor suppressor genes are inactivated through epigenetic modifications, rather than by genetic mechanisms, in sporadic cancers (Meeran et al., 2010; Su et al., 2018) . Accumulating evidence suggests that epigenetic modulators are important tools to improve the efficacy of disease prevention strategies (Ratovitski, 2017; Carlos-Reyes et al., 2019; Hassan et al., 2019) .
Dear Editor,
Gene expression is mediated by chromatin epigenetic changes, including DNA methylation, histone modifications, promoter-enhancer interactions, and non-coding RNA (microRNA and long non-coding RNA)-mediated regulation (Chen et al., 2017) . Approximately 50 % of all tumor suppressor genes are inactivated through epigenetic modifications, rather than by genetic mechanisms, in sporadic cancers (Meeran et al., 2010; Su et al., 2018) . Accumulating evidence suggests that epigenetic modulators are important tools to improve the efficacy of disease prevention strategies (Ratovitski, 2017; Carlos-Reyes et al., 2019; Hassan et al., 2019) .
Sulforaphane ([1-isothioyanato-4-(methyl-sulfinyl)butane], SFN) is a naturally occurring, sulfur-containing isothiocyanate derivative that is found in the seeds and sprouts of cruciferous vegetables such as broccoli, cabbage, cauliflower, and kale (Vanduchova et al., 2019) . Because SFN induces the nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element pathway that induces the cellular defense against oxidative stress (Trio et al., 2016) , SFN has received increased attention because it acts as an antioxidant, antimicrobial, anti-inflammatory, and anticancer agent (Vanduchova et al., 2019) . Various mechanisms, including apoptosis activation, nuclear factor-κB pathway inhibition, and cell cycle arrest induction, have been proposed to explain the beneficial effects of SFN in preventing multiple types of cancer (Tortorella et al., 2015) . Indeed, the increasing attention of SFN as an epigenetic modulator continues to contribute to new developments in clinical trials.
This letter presents a summary of key recent studies investigating the function of SFN as an epigenetic modulator in several human diseases (Table 1) . I believe that this letter will stimulate future research on the development of SFN as an epigenetic modulator for successful chemoprevention and alternative therapeutic approaches. SFN demethylated CpG sites of the promoter of miR-9-3, known as a tumor suppressor miRNA, and reactivated miR-9-3 expression via attenuating enzymatic DNA methyltransferase (DNMT) activity and protein expression of DNMT3a and histone deacetylase 1, 3 and 6 in human lung cancer A549 cells. Gao et al., 2018 SFN-induced cell cycle arrest, nitro-oxidative stress and genotoxicity were accompanied by global DNA hypomethylation, decreased levels of DNA methyltransferase 1 and 3B, diminished pools of N 6 -methyladenosine RNA methylation and changes in microRNA profile (upregulation of sixty microRNAs and downregulation of thirty-two microRNAs) in breast cancer cells. Lewinska et al., 2017 SFN reduced the tumor formation and growth of melanoma stem cells by reducing histone methyltransferase EZH2 levels and histone H3 lysine 27 trimethylation. Fisher et al., 2016 SFN inhibited the expression and activity of human telomerase reverse transcriptase, the catalytic subunit of telomerase, through modulation of acetylation of histone H3 lysine 18 and di-methylation of histone H3 lysine 4, resulting in induction of cell death and growth arrest in prostate cancer cells. Abbas et al., 2016 SFN led to hypomethylation of tumor suppressor gene promoters, phosphatase and tensin homologue (PTEN) and retinoic acid receptor beta 2 (RARbeta2), resulting in up-regulation of expression of these genes in human breast cancer cells.
Lubecka-Pietruszewska et al., 2015 SFN reversed the expression of silenced tumor suppressor genes, including RARβ (retinoic acid receptor beta), CDH1 (cadherin 1) and DAPK1 (death-associated protein kinase 1) through the reversal in the 5′-CpG island methylation and by inhibiting the activity of DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Ali Khan et al., 2015 Effects
Epigenetic regulation Reference
Treatment of Alzheimer's disease SFN increased the expression of Nrf2 and promoted the nuclear translocation of Nrf2 by reducing DNA demethylation levels of the Nrf2 promoter, thus leading to antioxidative (reducing reactive oxygen species and malondialdehyde, and increasing superoxide dismutase) and anti-inflammatory effects (decreasing the levels of pro-inflammatory cytokines) in a cellular model of Alzheimer's disease. Zhao et al., 2018 Cell protection SFN protects against ethanol-induced apoptosis by decreasing ethanol-induced reduction of H3K4me3 at the promoter regions of the Snail1 transcriptional factor, restoring the expression of Snail1 and epithelial-mesenchymal transition in ethanol-exposed neural crest cells. Li et al., 2019 SFN restored the expression of B-cell leukemia/lymphoma-2 (Bcl-2) and attenuated ethanol-induced apoptosis through restoring acetyl-histone H3 binding to Bcl-2 promoter in ethanolexposed neural crest cells. Yuan et al., 2018 Anti-inflammatory effects SFN inhibited expression of LPS (bacterial lipopolysaccharide)-induced cluster of differentiation 14 (CD14) that enhances the inflammatory response, through the suppression of CD14 gene body (coding sequence) methylation that might be caused by the downregulation of DNA methyltransferase 3a expression in pulmonary alveolar macrophages. Yang et al., 2015 
